• 4 Citations
  • 1 h-Index
20182019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Martina Bonacini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Giant Cell Arteritis Medicine & Life Sciences
Temporal Arteries Medicine & Life Sciences
Tuftsin Medicine & Life Sciences
Peptide Nucleic Acids Medicine & Life Sciences
Phosphorylcholine Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Interleukin-6 Medicine & Life Sciences
lung neoplasms Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

  • 4 Citations
  • 1 h-Index
  • 4 Article
1 Citation (Scopus)

64 Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells

Croci, S., Manicardi, A., Rubagotti, S., Bonacini, M., Iori, M., Capponi, P. C., Cicoria, G., Parmeggiani, M., Salvarani, C., Versari, A., Corradini, R. & Asti, M., Dec 1 2019, In : Scientific Reports. 9, 1, 3376.

Research output: Contribution to journalArticle

Peptide Nucleic Acids
Fluorescein
MicroRNAs
Molecular Imaging
Giant Cell Arteritis

Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis

Pipitone, N., Muratore, F., Tamagnini, I., Cavazza, A., Cimino, L., Boiardi, L., Restuccia, G., Croci, S., Bonacini, M. & Salvarani, C., Mar 1 2019, In : Clinical and Experimental Rheumatology. 37, 2, p. 98-103 6 p.

Research output: Contribution to journalArticle

Temporal Arteries
Giant Cell Arteritis
Interleukin-6
Biopsy
Staining and Labeling

The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis

Croci, S., Bonacini, M., Muratore, F., Caruso, A., Fontana, A., Boiardi, L., Soriano, A., Cavazza, A., Cimino, L., Belloni, L., Perry, O., Fridkin, M., Parmeggiani, M., Blank, M., Shoenfeld, Y. & Salvarani, C., Mar 1 2019, In : Journal of Autoimmunity. 98, p. 113-121 9 p.

Research output: Contribution to journalArticle

Tuftsin
Giant Cell Arteritis
Phosphorylcholine
Temporal Arteries
Blood Cells
2 Citations (Scopus)

Higher expression of MIR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients

Bisagni, A., Pagano, M., Maramotti, S., Zanelli, F., Bonacini, M., Tagliavini, E., Braglia, L., Paci, M., Mozzarelli, A. & Croci, S., Apr 1 2018, In : PLoS One. 13, 4, e0196350.

Research output: Contribution to journalArticle

lung neoplasms
Non-Small Cell Lung Carcinoma
Cells
Epidermal Growth Factor Receptor
Tumors